Patent Expiries Accelerate Brazilian Biopharmaceutical Production for Cancer

Brazil is leveraging patent expirations to ramp up domestic production of cancer biopharmaceuticals, reducing import dependence. The move signals a strategic shift in national health policy, though details on specific drugs and timelines remain unclear. This could lower treatment costs and improve access, but production scale and regulatory hurdles are uncertain.